Relationship Between the Incidence of Metabolic Syndrome and Breast Cancer
- 7 October 2025
- journal article
- research article
- Published by Springer Nature in Cardiovascular Drugs and Therapy
- Vol. 40 (3) , 1035-1046
Abstract
Purpose Breast cancer affects females from puberty onward, with incidence rates increasing with age. Although metabolic syndrome (MetS) has reportedly increased the incidence of almost all cancers, no clear consensus on the role of MetS in breast cancer development exists. We aimed to clarify the effects of MetS on breast cancer incidence. Methods To investigate this relationship, we analyzed Japanese healthcare data of females from 2005 to 2020 and examined the incidence of breast cancer. MetS was evaluated based on the Japanese criteria or the NCEP ATP III guidelines at enrollment. Of 1,144,791 participants without missing data in our general public cohort, 32,775 with breast cancer at the beginning of the observation period were excluded; 54,330 participants with breast cancer were identified during the observation period. Results Both pre-stage MetS and MetS, defined using the Japanese criteria, were associated with the less frequent incidence of breast cancer (hazard ratios [HRs], 0.90; 95% CI, 0.86–0.94; p < 0.005: HR, 0.83; 95% CI, 0.80–0.87; p < 0.005). Furthermore, MetS using NCEP ATP III was associated with the lower HR (0.87: CI, 0.84–0.90; p < 0.005), and the number of the factors from 1 to 5 was gradually associated with the lower HRs. Analysis according to age group revealed that this observation was the most prominent in the < 50-year-old group. Conclusion MetS is associated with the less frequent breast cancer incidence in females, especially aged < 50 years.Keywords
All Related Versions
Funding Information
- Japan Heart Foundation (Grant to Kitakaze)
This publication has 32 references indexed in Scilit:
- Overview of the Epidemiology of Pancreatic Cancer Focusing on the JACC StudyJournal of Epidemiology, 2005
- Vascular Endothelial Growth Factor and AngiogenesisPharmacological Reviews, 2004
- Insulin-like growth factor-I and cancer riskGrowth Hormone & IGF Research, 2004
- Epidemiology of breast cancerThe Lancet Oncology, 2001
- Estrogen and the Risk of Breast CancerNew England Journal of Medicine, 2001
- AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinomaGastroenterology, 1999
- Western nutrition and the insulin resistance syndrome: A link to breast cancerEuropean Journal of Clinical Nutrition, 1999
- Reducing cancer risk in women through lifestyle-mediated changes in hormone levels.1990
- Pancreas Cancer and Smoking, Beverage Consumption, and Past Medical History2JNCI: Journal of the National Cancer Institute, 1986
- Do regular ovulatory cycles increase breast cancer risk?Cancer, 1985